For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
Leaders of the Common Sense Oncology initiative, launched 1.5 years ago as “a new patient-centered movement in cancer care,” outline principles for trial design, analysis, and reporting.
CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...
GlobalData on MSN4d
Maze Therapeutics doses first subject in Phase II AKD treatment trialMaze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...
The PACK trial 1 was a parallel-arm cluster randomised trial, assigning 48 clinics to the intervention arm (a training ...
The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...
News Medical on MSN1d
Low-dose semaglutide reduces alcohol consumption and cravings in early trialResearch reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse events following troculeucel therapy. Troculeucel ...
Researchers will launch a randomized clinical trial to assess whether PGx-guided care helps keep patients out of the ER and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback